1795.TW
Lotus Pharmaceutical Co Ltd
Price:  
215 
TWD
Volume:  
630,952
Taiwan, Province of China | Pharmaceuticals

1795.TW DCF Valuation - Growth Exit 5Y

46.2 %
Upside

What is the DCF valuation of 1795.TW?

The Discounted Cash Flow (DCF) valuation of Lotus Pharmaceutical Co Ltd (1795.TW) is 314.32 TWD. With the latest stock price at 215.00 TWD, the upside of Lotus Pharmaceutical Co Ltd based on DCF is 46.2%.

Is 1795.TW a buy or a sell?

Based on the latest price of 215.00 TWD and our DCF valuation, Lotus Pharmaceutical Co Ltd (1795.TW) is a buy. Buying 1795.TW stocks now will result in a potential gain of 46.2%.

Range Selected
WACC / Discount Rate4.9% - 7.1%6.0%
Long-term Growth Rate 0.0% - 1.0%0.5%
Fair Price242.76 - 444.15314.32
Upside12.9% - 106.6%46.2%
215.00 TWD
Stock Price
314.32 TWD
Fair Price
REVENUE & EXPENSES
CAPEX
D&A
WORKING CAPITAL
TERMINAL VALUE

1795.TW DCF Valuation: Revenue & Expenses Forecast

(TWD in millions)Projections
12-202412-202512-202612-202712-202812-2029
Revenue18,58421,05621,45021,88123,54925,763
% Growth
10%13%2%2%8%9%
Cost of goods sold(7,660)(8,679)(8,841)(9,019)(9,707)(10,619)
% of Revenue41%41%41%41%41%41%
Selling, G&A expenses(4,130)(4,679)(4,767)(4,863)(5,234)(5,726)
% of Revenue22%22%22%22%22%22%
Research & Development(774)(877)(893)(911)(981)(1,073)
% of Revenue4%4%4%4%4%4%
Net interest & other expenses340385392400430471
% of Revenue2%2%2%2%2%2%
Tax expense(1,294)(1,517)(1,545)(1,576)(1,697)(1,856)
Tax rate20%21%21%21%21%21%
Net profit5,0665,6885,7955,9116,3626,960
% Margin27%27%27%27%27%27%